Paid Clinical Trials Delaware

Discover 254 paid clinical trials in Delaware. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 254

Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Annapolis MD, Newark DE, Little Silver NJ, Norfolk VAshow 34 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

Optimizing TreatmentOptimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

Recruiting

PHASE3

Sponsor:

HELP for NOWS Consortium

Location:

Wilmington DE, Atlantic City NJ, Philadelphia PA, Rochester NYshow 16 more

Code:

NCT05980260

Conditions

Neonatal Opiate Withdrawal Syndrome

Eligibility Criteria

Sex: All

Age: 1 - 48

Healthy Volunteers: Not accepted

Interventions

Symptom-based Dosing Approach

Scheduled Opioid Taper Approach

Cema-celConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting

PHASE2

Sponsor:

Allogene Therapeutics

Location:

Newark DE, Washington DC, Fairfax VA, East Brunswick NJshow 33 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

Psychosocial InterventionHEARTPrep: A Virtually-delivered Psychosocial Intervention for Mothers Expecting a Baby With Congenital Heart Disease

Recruiting

Sponsor:

Nemours Children's Clinic

Location:

Wilmington DE

Code:

NCT05129631

Conditions

Congenital Heart Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HEARTPrep

Observational StudyCerebral Palsy Hip Outcomes Project - International Multi-centre Study

Recruiting

Sponsor:

Holland Bloorview Kids Rehabilitation Hospital

Location:

Wilmington DE, New York NY, Boston MA, Torontoshow 7 more

Code:

NCT01987882

Conditions

Cerebral Palsy

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

Observational StudyNational Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Wilmington DE, Baltimore MD, Philadelphia PA, Washington DCshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Surgery vs. TreatmentComparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Recruiting

PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Lewes DE, Rehoboth Beach DE, Millville DE, Elkton MDshow 180 more

Code:

NCT06632327

Conditions

Resectable Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Stage IIIB Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Procedure

Cisplatin

Carboplatin

Pemetrexed

Gemcitabine

Petosemtamab vs. PembrolizumabA Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Recruiting

PHASE3

Sponsor:

Merus N.V.

Location:

Newark DE, Philadelphia PA, Washington DC, Norfolk VAshow 24 more

Code:

NCT06525220

Conditions

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Petosemtamab

Pembrolizumab

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Newark DE, Lutherville MD, Philadelphia PA, Washington DCshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Amivantamab-SubcutaneousTargeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Milford DE, Dover DE, Ephrata PA, York PAshow 85 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Popular cities in Delaware

Newark Wilmington Dover